Participants in the liraglutide group demonstrated a similar pattern, with mean weight loss decreasing from 8.5% at week 26 to 7.2% at week 32, indicating partial weight gain after discontinuation [1]
As of 2026, with improved regulatory clarity and access through licensed providers, these peptides are becoming more structured, safer, and clinically accessible but should always be used under professional guidance.
Anything darker yellow or brownish suggests degradation, throw it out
Delivery & Support Discrete shipping to your door with ongoing support
The purchaser is responsible for confirming compatibility and ensuring that acquisition, storage, preparation, transport, use and disposal comply with applicable laws and institutional requirements